Dr. Medhat Osman
Claim this profileSaint Louis University
Studies Prostate Cancer
Studies Cancer
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Medhat Osman is currently running
More about Medhat Osman
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Medhat Osman has experience with
- 177Lu-PSMA-617
- 68Ga-PSMA-11
- ARDT
- ADT
- F18-Fluoride PET/CT
- TC-MDP
Breakdown of trials Medhat Osman has run
Prostate Cancer
Bone Marrow Disease
Bone Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Medhat Osman specialize in?
Medhat Osman focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Medhat Osman currently recruiting for clinical trials?
Yes, Medhat Osman is currently recruiting for 1 clinical trial in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Medhat Osman has studied deeply?
Yes, Medhat Osman has studied treatments such as 177Lu-PSMA-617, 68Ga-PSMA-11, ARDT.
What is the best way to schedule an appointment with Medhat Osman?
Apply for one of the trials that Medhat Osman is conducting.
What is the office address of Medhat Osman?
The office of Medhat Osman is located at: Saint Louis University, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Saint Louis University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.